tiprankstipranks
Amphastar Pharmaceuticals (AMPH)
NASDAQ:AMPH
US Market
AMPH
Amphastar Pharmaceuticals
RESEARCH TOOLSreports
Want to see AMPH full AI Analyst Report?

Amphastar Pharmaceuticals (AMPH) Ratios

435 Followers

Amphastar Pharmaceuticals Ratios

AMPH's free cash flow for Q2 2026 was $0.51. For the 2026 fiscal year, AMPH's free cash flow was decreased by $ and operating cash flow was $0.25. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 2.40 4.02 3.07 2.17 3.99
Quick Ratio
 1.71 2.90 2.19 1.70 2.90
Cash Ratio
 0.85 1.08 0.87 0.64 1.65
Solvency Ratio
 0.13 0.19 0.26 0.21 0.56
Operating Cash Flow Ratio
 0.70 0.99 1.23 0.81 0.94
Short-Term Operating Cash Flow Coverage
 74.20 95.13 911.91 420.88 29.28
Net Current Asset Value
$ -344.66M$ -204.48M$ -311.10M$ -383.89M$ 164.99M
Leverage Ratios
Debt-to-Assets Ratio
 0.39 0.40 0.41 0.41 0.14
Debt-to-Equity Ratio
 0.90 0.83 0.89 0.98 0.19
Debt-to-Capital Ratio
 0.47 0.45 0.47 0.49 0.16
Long-Term Debt-to-Capital Ratio
 0.44 0.44 0.45 0.48 0.12
Financial Leverage Ratio
 2.27 2.07 2.15 2.37 1.40
Debt Service Coverage Ratio
 5.29 6.89 8.10 7.55 25.08
Interest Coverage Ratio
 4.37 5.51 6.77 7.25 58.23
Debt to Market Cap
 0.60 0.49 0.33 0.20 0.06
Interest Debt Per Share
 16.37 14.58 14.06 13.48 2.15
Net Debt to EBITDA
 2.66 2.29 1.80 1.99 -0.37
Profitability Margins
Gross Profit Margin
47.68%49.46%51.08%54.49%49.87%
EBIT Margin
17.55%20.71%30.07%30.81%23.63%
EBITDA Margin
23.94%29.49%37.89%37.29%29.29%
Operating Profit Margin
15.66%19.50%28.06%30.57%21.54%
Pretax Profit Margin
13.98%17.17%25.85%26.28%23.02%
Net Profit Margin
10.76%13.63%21.79%21.34%18.31%
Continuous Operations Profit Margin
10.76%13.63%21.79%21.34%18.31%
Net Income Per EBT
76.99%79.35%84.32%81.21%79.56%
EBT Per EBIT
89.27%88.05%92.10%85.98%106.85%
Return on Assets (ROA)
4.50%6.02%10.11%9.09%12.32%
Return on Equity (ROE)
10.11%12.44%21.78%21.51%17.29%
Return on Capital Employed (ROCE)
7.72%9.54%14.63%15.30%16.61%
Return on Invested Capital (ROIC)
5.90%7.52%12.28%12.38%13.09%
Return on Tangible Assets
6.67%9.23%16.17%15.29%12.97%
Earnings Yield
7.76%7.84%8.87%4.61%6.72%
Efficiency Ratios
Receivables Turnover
 5.04 5.01 5.30 5.58 5.62
Payables Turnover
 13.20 11.16 11.74 11.53 12.20
Inventory Turnover
 2.12 2.06 2.33 2.77 2.41
Fixed Asset Turnover
 1.88 2.04 2.12 2.04 1.89
Asset Turnover
 0.42 0.44 0.46 0.43 0.67
Working Capital Turnover Ratio
 1.74 1.72 2.34 2.35 2.00
Cash Conversion Cycle
 216.72 217.55 194.43 165.46 186.20
Days of Sales Outstanding
 72.43 72.79 68.83 65.40 64.96
Days of Inventory Outstanding
 171.94 177.46 156.70 131.72 151.16
Days of Payables Outstanding
 27.65 32.70 31.10 31.66 29.92
Operating Cycle
 244.37 250.25 225.53 197.12 216.11
Cash Flow Ratios
Operating Cash Flow Per Share
 4.23 3.34 4.41 3.80 1.84
Free Cash Flow Per Share
 3.50 2.59 3.56 3.01 1.34
CapEx Per Share
 0.73 0.75 0.85 0.79 0.50
Free Cash Flow to Operating Cash Flow
 0.83 0.78 0.81 0.79 0.73
Dividend Paid and CapEx Coverage Ratio
 5.82 4.48 5.20 4.81 3.71
Capital Expenditure Coverage Ratio
 5.82 4.48 5.20 4.81 3.71
Operating Cash Flow Coverage Ratio
 0.27 0.24 0.33 0.29 0.87
Operating Cash Flow to Sales Ratio
 0.25 0.22 0.29 0.28 0.18
Free Cash Flow Yield
14.96%9.68%9.58%4.87%4.79%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 13.32 12.75 11.27 21.70 14.89
Price-to-Sales (P/S) Ratio
 1.40 1.74 2.46 4.63 2.73
Price-to-Book (P/B) Ratio
 1.32 1.59 2.46 4.67 2.57
Price-to-Free Cash Flow (P/FCF) Ratio
 6.68 10.33 10.43 20.54 20.88
Price-to-Operating Cash Flow Ratio
 5.48 8.02 8.43 16.27 15.25
Price-to-Earnings Growth (PEG) Ratio
 -0.35 -0.35 0.73 0.42 0.33
Price-to-Fair Value
 1.32 1.59 2.46 4.67 2.57
Enterprise Value Multiple
 8.51 8.18 8.28 14.42 8.94
Enterprise Value
 1.49B 1.74B 2.30B 3.46B 1.31B
EV to EBITDA
 8.51 8.18 8.28 14.42 8.94
EV to Sales
 2.04 2.41 3.14 5.38 2.62
EV to Free Cash Flow
 9.72 14.33 13.33 23.84 20.06
EV to Operating Cash Flow
 8.05 11.13 10.77 18.88 14.65
Tangible Book Value Per Share
 4.63 4.77 2.92 0.54 10.12
Shareholders’ Equity Per Share
 17.60 16.88 15.12 13.25 10.89
Tax and Other Ratios
Effective Tax Rate
 0.23 0.21 0.16 0.19 0.20
Revenue Per Share
 16.73 15.40 15.11 13.35 10.28
Net Income Per Share
 1.80 2.10 3.29 2.85 1.88
Tax Burden
 0.77 0.79 0.84 0.81 0.80
Interest Burden
 0.80 0.83 0.86 0.85 0.97
Research & Development to Revenue
 0.13 0.12 0.10 0.11 0.15
SG&A to Revenue
 0.19 0.18 0.13 0.08 0.09
Stock-Based Compensation to Revenue
 0.04 0.04 0.03 0.03 0.04
Income Quality
 2.35 1.59 1.34 1.33 0.98
Currency in USD